FDA 483 - Pharmedica USA, LLC - November 07, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Pharmedica USA, LLC, an OTC drug manufacturer in Phoenix, AZ, was cited for significant deficiencies in its quality control unit and manufacturing processes. The inspection revealed a complete lack of a quality control unit, inadequate procedures to prevent microbiological contamination for sterile products, and a failure to perform essential testing for finished products and components. These issues indicate severe non-compliance with good manufacturing practices, particularly concerning product identity, strength, purity, and quality.
ID · a9c354d5-e577-40fc-89b7-339d57cbd575